Mosaic ImmunoEngineering Inc. (CPMV) stock
CPMVOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.33+0.00 (0.00%)
Close on Oct 19, 2026Market cap $2.41MP/E –Yield –
Mosaic ImmunoEngineering total assets
Total assets on the balance sheet at the end of each period.
Mosaic ImmunoEngineering's total assets was $3.28K at Jun 30, 2026. For fiscal 2025 it was $19.88K, down 86.0% from the year before. Over ten years it grew -44.2% a year on average. The highest annual figure on record is $12.60M in fiscal 2011.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.88K | -86.0% |
| FY2024 | Dec 31, 2024 | $141.61K | -21.1% |
| FY2023 | Dec 31, 2023 | $179.53K | -31.3% |
| FY2022 | Dec 31, 2022 | $261.28K | +46308.0% |
| FY2020 | May 31, 2020 | $563 | -100.0% |
| FY2019 | May 31, 2019 | $1.92M | -25.4% |
| FY2018 | May 31, 2018 | $2.58M | -31.4% |
| FY2017 | May 31, 2017 | $3.76M | -1.6% |
| FY2016 | May 31, 2016 | $3.82M | -26.2% |
| FY2015 | May 31, 2015 | $5.18M | -23.8% |
| FY2014 | May 31, 2014 | $6.80M | -19.2% |
| FY2013 | May 31, 2013 | $8.41M | +3.4% |
| FY2012 | May 31, 2012 | $8.14M | -35.4% |
| FY2011 | May 31, 2011 | $12.60M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $3.28K | -94.3% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $9.83K | -89.9% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $19.88K | -86.0% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $55.30K | +38.4% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $57.70K | +370.0% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $97.78K | +23.9% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $141.61K | -21.1% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $39.95K | -86.0% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $12.28K | -96.7% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $78.95K | -46.8% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $179.53K | -31.3% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $285.53K | -34.0% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $369.36K | +65.5% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $148.47K | -63.2% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $261.28K | +46308.0% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $432.93K | -58.6% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $223.15K | -82.6% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $403.59K | -75.1% |
| Q4 FY2020CQ2 2020 | May 31, 2020 | $563 | -100.0% |
| Q3 FY2020CQ1 2020 | Feb 29, 2020 | $1.04M | -52.1% |
| Q2 FY2020CQ4 2019 | Nov 30, 2019 | $1.28M | -41.0% |
| Q1 FY2020CQ3 2019 | Aug 31, 2019 | $1.62M | -31.4% |
| Q4 FY2019CQ2 2019 | May 31, 2019 | $1.92M | -25.4% |
| Q3 FY2019CQ1 2019 | Feb 28, 2019 | $2.18M | -25.0% |
| Q2 FY2019CQ4 2018 | Nov 30, 2018 | $2.17M | -30.2% |
| Q1 FY2019CQ3 2018 | Aug 31, 2018 | $2.36M | -32.5% |
| Q4 FY2018CQ2 2018 | May 31, 2018 | $2.58M | -31.4% |
| Q3 FY2018CQ1 2018 | Feb 28, 2018 | $2.91M | -29.0% |
| Q2 FY2018CQ4 2017 | Nov 30, 2017 | $3.11M | -29.2% |
| Q1 FY2018CQ3 2017 | Aug 31, 2017 | $3.50M | +1.2% |
| Q4 FY2017CQ2 2017 | May 31, 2017 | $3.76M | -1.6% |
| Q3 FY2017CQ1 2017 | Feb 28, 2017 | $4.09M | -6.9% |
| Q2 FY2017CQ4 2016 | Nov 30, 2016 | $4.39M | -10.8% |
| Q1 FY2017CQ3 2016 | Aug 31, 2016 | $3.46M | -31.3% |
| Q4 FY2016CQ2 2016 | May 31, 2016 | $3.82M | -26.2% |
| Q3 FY2016CQ1 2016 | Feb 29, 2016 | $4.39M | -21.2% |
| Q2 FY2016CQ4 2015 | Nov 30, 2015 | $4.93M | – |
| Q1 FY2016CQ3 2015 | Aug 31, 2015 | $5.03M | – |
| Q4 FY2015CQ2 2015 | May 31, 2015 | $5.18M | – |
| Q3 FY2015CQ1 2015 | Feb 28, 2015 | $5.58M | – |
See a number that looks wrong?